Free Trial
NASDAQ:TECX

Tectonic Therapeutic Q2 2024 Earnings Report

Tectonic Therapeutic logo
$22.31 +0.39 (+1.78%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$22.22 -0.09 (-0.40%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tectonic Therapeutic EPS Results

Actual EPS
-$3.81
Consensus EPS
-$1.96
Beat/Miss
Missed by -$1.85
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Q2 2024
Time
N/A
Conference Call Date
Tuesday, August 13, 2024
Conference Call Time
6:00PM ET

Upcoming Earnings

Tectonic Therapeutic's Q3 2025 earnings is scheduled for Wednesday, August 13, 2025

Tectonic Therapeutic Earnings Headlines

Tectonic (TECX) Q2 R&D Soars 142%
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Tectonic Therapeutic (NASDAQ:TECX) engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.

View Tectonic Therapeutic Profile

More Earnings Resources from MarketBeat